Filing Details
- Accession Number:
- 0001104659-18-049250
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-02 17:51:52
- Reporting Period:
- 2018-07-31
- Accepted Time:
- 2018-08-02 17:51:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1641640 | Nabriva Therapeutics Plc | NBRV | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1239650 | D Daniel Burgess | 1000 Continental Drive Suite 600 King Of Prussia PA 19406 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2018-07-31 | 36,000 | $2.75 | 36,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option | Acquisiton | 2018-08-01 | 15,000 | $0.00 | 15,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,000 | 2028-08-01 | No | 4 | A | Direct |
Footnotes
- The exercise price is $2.53 per share.
- The option award was granted on August 1, 2018. The option award will vest in full on August 1, 2019.
Billionaire Hedge Funds
